annual CFO:
$295.03M+$111.87M(+61.07%)Summary
- As of today (August 16, 2025), AMRX annual cash flow from operations is $295.03 million, with the most recent change of +$111.87 million (+61.07%) on December 31, 2024.
- During the last 3 years, AMRX annual CFO has risen by +$53.21 million (+22.00%).
- AMRX annual CFO is now -22.16% below its all-time high of $379.00 million, reached on December 31, 2020.
Performance
AMRX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$83.82M+$76.41M(+1031.47%)Summary
- As of today (August 16, 2025), AMRX quarterly cash flow from operations is $83.82 million, with the most recent change of +$76.41 million (+1031.47%) on June 30, 2025.
- Over the past year, AMRX quarterly CFO has increased by +$44.16 million (+111.36%).
- AMRX quarterly CFO is now -67.72% below its all-time high of $259.65 million, reached on December 31, 2018.
Performance
AMRX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$351.08M+$44.16M(+14.39%)Summary
- As of today (August 16, 2025), AMRX TTM cash flow from operations is $351.08 million, with the most recent change of +$44.16 million (+14.39%) on June 30, 2025.
- Over the past year, AMRX TTM CFO has increased by +$98.62 million (+39.06%).
- AMRX TTM CFO is now -26.57% below its all-time high of $478.10 million, reached on March 31, 2021.
Performance
AMRX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AMRX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +61.1% | +111.4% | +39.1% |
| 3 y3 years | +22.0% | +166.8% | +150.0% |
| 5 y5 years | +10000.0% | -53.2% | +10.7% |
AMRX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +365.1% | -40.9% | +166.8% | at high | +439.3% |
| 5 y | 5-year | -22.2% | >+9999.0% | -53.2% | +166.8% | -26.6% | +439.3% |
| alltime | all time | -22.2% | +1634.8% | -67.7% | +166.8% | -26.6% | +590.7% |
AMRX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $83.82M(+1031.5%) | $351.08M(+14.4%) |
| Mar 2025 | - | $7.41M(-93.7%) | $306.92M(+4.0%) |
| Dec 2024 | $295.03M(+61.1%) | $118.08M(-16.7%) | $295.10M(-5.7%) |
| Sep 2024 | - | $141.77M(+257.5%) | $312.84M(+23.9%) |
| Jun 2024 | - | $39.66M(-999.3%) | $252.46M(+25.3%) |
| Mar 2024 | - | -$4.41M(-103.2%) | $201.46M(-41.7%) |
| Dec 2023 | $183.16M(+188.7%) | $135.82M(+66.9%) | $345.58M(+85.3%) |
| Sep 2023 | - | $81.39M(-817.4%) | $186.46M(-6.1%) |
| Jun 2023 | - | -$11.35M(-108.1%) | $198.65M(+135.2%) |
| Mar 2023 | - | $139.71M(-699.8%) | $84.47M(+29.8%) |
| Dec 2022 | $63.44M(-73.8%) | -$23.29M(-124.9%) | $65.10M(-57.1%) |
| Sep 2022 | - | $93.57M(-174.5%) | $151.65M(+8.0%) |
| Jun 2022 | - | -$125.52M(-204.3%) | $140.45M(-34.4%) |
| Mar 2022 | - | $120.34M(+90.2%) | $214.03M(-11.5%) |
| Dec 2021 | $241.82M(-36.2%) | $63.26M(-23.2%) | $241.82M(-15.0%) |
| Sep 2021 | - | $82.36M(-258.6%) | $284.52M(+15.2%) |
| Jun 2021 | - | -$51.93M(-135.1%) | $246.93M(-48.4%) |
| Mar 2021 | - | $148.13M(+39.8%) | $478.10M(+26.1%) |
| Dec 2020 | $379.00M(>+9900.0%) | $105.96M(+136.6%) | $379.00M(+70.6%) |
| Sep 2020 | - | $44.78M(-75.0%) | $222.15M(-30.0%) |
| Jun 2020 | - | $179.24M(+265.6%) | $317.29M(+99.4%) |
| Mar 2020 | - | $49.03M(-196.3%) | $159.14M(+9233.8%) |
| Dec 2019 | $1.71M | -$50.89M(-136.4%) | $1.71M(-99.5%) |
| Sep 2019 | - | $139.91M(+563.3%) | $312.25M(+33.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $21.09M(-119.5%) | $234.46M(+104.3%) |
| Mar 2019 | - | -$108.41M(-141.8%) | $114.79M(-54.1%) |
| Dec 2018 | $250.23M(+6.9%) | $259.65M(+317.9%) | $250.23M(-2756.1%) |
| Sep 2018 | - | $62.13M(-163.0%) | -$9.42M(-86.8%) |
| Jun 2018 | - | -$98.58M(-464.7%) | -$71.55M(-364.7%) |
| Mar 2018 | - | $27.03M | $27.03M |
| Dec 2017 | $234.19M(+213.9%) | - | - |
| Dec 2016 | $74.60M(+3.7%) | - | - |
| Dec 2015 | $71.93M(+119.2%) | - | - |
| Dec 2014 | $32.82M(-78.1%) | - | - |
| Dec 2013 | $149.94M(+41.2%) | - | - |
| Dec 2012 | $106.21M(+1570.5%) | - | - |
| Dec 2011 | $6.36M(-97.5%) | - | - |
| Dec 2010 | $249.76M(-3161.9%) | - | - |
| Dec 2009 | -$8.16M(-112.6%) | - | - |
| Dec 2008 | $64.56M(-45.8%) | - | - |
| Dec 2007 | $119.01M(-2166.2%) | - | - |
| Dec 2006 | -$5.76M(-127.2%) | - | - |
| Dec 2005 | $21.15M(-210.0%) | - | - |
| Dec 2003 | -$19.22M(+26.5%) | - | - |
| Dec 2002 | -$15.20M(-15.0%) | - | - |
| Dec 2001 | -$17.88M(+11.7%) | - | - |
| Dec 2000 | -$16.00M(+137.6%) | - | - |
| Dec 1999 | -$6.74M(+49.0%) | - | - |
| Dec 1998 | -$4.52M | - | - |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual CFO year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly CFO year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM CFO year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual cash flow from operations?
The current annual CFO of AMRX is $295.03M
What is the all time high annual CFO for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual cash flow from operations is $379.00M
What is Amneal Pharmaceuticals, Inc. annual CFO year-on-year change?
Over the past year, AMRX annual cash flow from operations has changed by +$111.87M (+61.07%)
What is Amneal Pharmaceuticals, Inc. quarterly cash flow from operations?
The current quarterly CFO of AMRX is $83.82M
What is the all time high quarterly CFO for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly cash flow from operations is $259.65M
What is Amneal Pharmaceuticals, Inc. quarterly CFO year-on-year change?
Over the past year, AMRX quarterly cash flow from operations has changed by +$44.16M (+111.36%)
What is Amneal Pharmaceuticals, Inc. TTM cash flow from operations?
The current TTM CFO of AMRX is $351.08M
What is the all time high TTM CFO for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM cash flow from operations is $478.10M
What is Amneal Pharmaceuticals, Inc. TTM CFO year-on-year change?
Over the past year, AMRX TTM cash flow from operations has changed by +$98.62M (+39.06%)